12/20/2024 6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/03/2024 7:03 AM | Galectin Therapeutics (Filer)
| Form DEF 14A | |
12/03/2024 7:04 AM | Galectin Therapeutics (Filer)
| Form DEFA14A | |
12/03/2024 7:05 AM | Galectin Therapeutics (Filer)
| Form ARS | |
11/14/2024 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
10/23/2024 12:39 PM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 3:12 PM | FREEMAN KEVIN D (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:10 PM | Boudes Pol F (Reporting) Galectin Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024 7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/26/2024 7:08 AM | Galectin Therapeutics (Issuer) Zordani Richard A. Jr. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/05/2024 7:41 AM | Galectin Therapeutics (Issuer) Jamil Khurram (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 7:38 AM | Galectin Therapeutics (Issuer) Jamil Khurram (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/01/2024 6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/23/2024 8:43 AM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4/A | |
07/23/2024 8:38 AM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 12:55 PM | FREEMAN KEVIN D (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 1:14 PM | Galectin Therapeutics (Issuer) Zordani Richard A. Jr. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 12:27 PM | Galectin Therapeutics (Issuer) LEWIS JOEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 10:37 AM | CZIRR JAMES C (Reporting) Galectin Therapeutics (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
04/09/2024 3:42 PM | FREEMAN KEVIN D (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 6:51 AM | Galectin Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/29/2024 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 11:50 AM | Galectin Therapeutics (Issuer) LEWIS JOEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 7:50 AM | CARSON BENJAMIN SR (Reporting) Galectin Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/16/2024 10:23 AM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 7:07 AM | Galectin Therapeutics (Issuer) LEWIS JOEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |